HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 54462769, compound → HCID 22127046, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 54462769 | HCID 54462769 | — |
| Catalyst | Zinc bromide | HCID 10421208 | — |
| Product | HCID 22127046 | HCID 22127046 | — |
Reaction Steps
In an analogous manner to that described in Example 125 (h), from tert-butyl (3RS,4RS)-4-[2-[3-(2-chlorophenyl)-[1,2,4]oxadiazol-5-ylmethoxy]-pyrimidin-5-yl]-3-(naphthalen-2-ylmethoxy)-piperidine-1-carboxylate by cleavage of the BOC group by means of anhydrous zinc bromide there was obtained 2-[3-(2-chloro-phenyl)-[1,2,4]oxadiazol-5-ylmethoxy]-5-[(3RS,4RS)-3-(naphthalen-2-ylmethoxy)-piperidin-4-yl]-pyrimidine in the form of an amorphous yellowish solid; MS: 528 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06051712 |
| Source dataset | uspto-grants-2000_04 |
| ORD ID | ord-92a8e5a13f1b4ecc9d8440533b14f8cc |
| Source note | uspto-grants-2000_04 |